Rokit Genomics Partners with Bionexus to Commercialize AI-Based Single-Cell Analysis
Building an Automated Single-Cell Transcriptome Analysis Model
Identifying Candidate Biomarkers Using AI
Rokit Genomics, a subsidiary of Rokit Healthcare, announced on May 19 that it has signed a memorandum of understanding (MOU) with Bionexus to jointly develop and commercialize an artificial intelligence (AI)-based single-cell transcriptome analysis service.
The core objective of this agreement is to build an automated single-cell transcriptome analysis model by combining Rokit Genomics' capabilities in single-cell analysis with Bionexus' AI-driven bio big data technology.
The two companies will work together on developing single-cell transcriptome linkage services using AI-based bio big data, facilitating technology exchanges for the development of AI-driven experimental and analytical services, jointly developing medical information collection and analysis technologies, and cooperating on healthcare commercialization initiatives.
This collaboration model is structured so that disease-related research hypotheses and candidate biomarkers are identified from single-cell transcriptome data using AI, and these are then linked for laboratory validation.
Rokit Genomics is responsible for operating the single-cell analysis pipeline, validating candidate biomarkers, establishing protocols, and interpreting results. Bionexus will handle AI-driven hypothesis generation and the development of automated analysis and reporting systems.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Rokit Genomics representative stated, "This collaboration will serve as an opportunity to fundamentally change the paradigm of analysis in the most prominent field of the genomics market—single-cell transcriptomics—by fully integrating AI technology," adding, "We will accelerate precision medicine and healthcare commercialization to solidify our competitiveness in the global omics market."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.